Canine Anaplasmosis: An Increasing Concern in Tick-Borne Disease Management

May 14, 2026

Canine anaplasmosis is a tick-borne disease caused mainly by Anaplasma phagocytophilum and Anaplasma platys. It is transmitted through infected tick bites and is increasingly recognized in global small animal practice.

 

Epidemiology (with data)

Reported exposure rates vary by region:

Region Reported Seroprevalence
United States (endemic areas) 3%–15%
Europe (general range) 10%–20%
High tick-density zones Up to >25% (local studies)

CDC surveillance data also shows a steady rise in Anaplasma-related infections in tick-endemic regions over the past decade, linked to expanding tick habitats.

 

Clinical Presentation

Clinical signs are often non-specific:

  • Fever and lethargy
  • Loss of appetite
  • Lameness / joint pain
  • Thrombocytopenia (common lab finding)
  • Some dogs may remain subclinical

Because symptoms overlap with other tick-borne diseases, laboratory confirmation is essential.

 

Diagnostic Approach

Common veterinary diagnostic workflow:

Method Role in Diagnosis Notes
Rapid antibody test First-line screening Fast, suitable for clinics
CBC (blood test) Supportive evidence Platelet reduction is common
PCR testing Confirmation High specificity

Rapid tests are widely used in frontline veterinary settings due to speed and ease of use.

 

Industry Relevance

With expanding tick distribution and increased pet movement, canine anaplasmosis has become an important target in routine vector-borne disease screening. Early detection supports better clinical outcomes and disease control.

 

Previous: No Information